APT Medical Inc.
688617
주식 순위
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
주가
$38.62
시가총액
$5.47B
변동 (1일)
0.19%
변동 (1년)
-17.07%
국가
CN
거래 APT Medical Inc. (688617)
카테고리
Healthcare
APT Medical Inc. (688617)의 매출
Jun 2026 기준 매출 TTM: $433.73M
APT Medical Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $433.73M입니다. 2024년에 회사는 $283.02M의 수익을 올렸으며 이는 2023년의 $233.13M 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
APT Medical Inc.의 수익 기록 (2017 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $433.73M | 17.44% |
| 2025 | $369.32M | 30.49% |
| 2024 | $283.02M | 21.40% |
| 2023 | $233.13M | 32.24% |
| 2022 | $176.29M | 35.21% |
| 2021 | $130.38M | 77.65% |
| 2020 | $73.39M | 26.51% |
| 2019 | $58.01M | 65.05% |
| 2018 | $35.15M | 49.30% |
| 2017 | $23.54M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $48.23B | 11,019.58% |
US
|
|
| $37.54B | 8,555.60% |
IE
|
|
| $25.84B | 5,856.92% |
US
|
|
| $21.00B | 4,740.79% |
US
|
|
| $26.02B | 5,898.66% |
DE
|
